Prokidney PROK
NASDAQ PROK
$1.44 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Prokidney (PROK) Preferred Stock Liabilities (2021 - 2022)

Updated

Prokidney (PROK) recorded Preferred Stock Liabilities of $250.37 million in Q2 2022, up 0.1% from the prior quarter.

Analysis

Prokidney (PROK) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

At the end of FY2021, Prokidney reported Preferred Stock Liabilities of $250.01 million.

  • Per Business Quant, the preceding three quarters came in at $250 million (Q1 2022), $250.01 million (Q4 2021) and $250 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Prokidney 274.24 Mn -213.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 250.37 Mn
Mar 31, 2022 250.00 Mn
Dec 31, 2021 250.01 Mn
Sep 30, 2021 250.00 Mn
API Access

Prokidney Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PROK&period=max&api_key=YOUR_API_KEY